Clinical dataset labels are rarely certain as annotators disagree and confidence is not uniform across cases. Typical aggregation procedures, such as majority voting, obscure this variability. In simple experiments on medical imaging benchmarks, accounting for the confidence in binary labels significantly impacts model rankings. We therefore argue that machine-learning evaluations should explicitly account for annotation uncertainty using probabilistic metrics that directly operate on distributions. These metrics can be applied independently of the annotations' generating process, whether modeled by simple counting, subjective confidence ratings, or probabilistic response models. They are also computationally lightweight, as closed-form expressions have linear-time implementations once examples are sorted by model score. We thus urge the community to release raw annotations for datasets and to adopt uncertainty-aware evaluation so that performance estimates may better reflect clinical data.

Recent advances in vision-language models (VLMs) have achieved remarkable performance on standard medical benchmarks, yet their true clinical reasoning ability remains unclear. Existing datasets predominantly emphasize classification accuracy, creating an evaluation illusion in which models appear proficient while still failing at high-stakes diagnostic reasoning. We introduce Neural-MedBench, a compact yet reasoning-intensive benchmark specifically designed to probe the limits of multimodal clinical reasoning in neurology. Neural-MedBench integrates multi-sequence MRI scans, structured electronic health records, and clinical notes, and encompasses three core task families: differential diagnosis, lesion recognition, and rationale generation. To ensure reliable evaluation, we develop a hybrid scoring pipeline that combines LLM-based graders, clinician validation, and semantic similarity metrics. Through systematic evaluation of state-of-the-art VLMs, including GPT-4o, Claude-4, and MedGemma, we observe a sharp performance drop compared to conventional datasets. Error analysis shows that reasoning failures, rather than perceptual errors, dominate model shortcomings. Our findings highlight the necessity of a Two-Axis Evaluation Framework: breadth-oriented large datasets for statistical generalization, and depth-oriented, compact benchmarks such as Neural-MedBench for reasoning fidelity. We release Neural-MedBench at https://neuromedbench.github.io/ as an open and extensible diagnostic testbed, which guides the expansion of future benchmarks and enables rigorous yet cost-effective assessment of clinically trustworthy AI.

Identifying objective neuroimaging biomarkers to forecast Alzheimer's disease (AD) progression is crucial for timely intervention. However, this task remains challenging due to the complex dysfunctions in the spatio-temporal characteristics of underlying brain networks, which are often overlooked by existing methods. To address these limitations, we develop an interpretable spatio-temporal graph neural network framework to predict future AD progression, leveraging dual Stochastic Differential Equations (SDEs) to model the irregularly-sampled longitudinal functional magnetic resonance imaging (fMRI) data. We validate our approach on two independent cohorts, including the Open Access Series of Imaging Studies (OASIS-3) and the Alzheimer's Disease Neuroimaging Initiative (ADNI). Our framework effectively learns sparse regional and connective importance probabilities, enabling the identification of key brain circuit abnormalities associated with disease progression. Notably, we detect the parahippocampal cortex, prefrontal cortex, and parietal lobule as salient regions, with significant disruptions in the ventral attention, dorsal attention, and default mode networks. These abnormalities correlate strongly with longitudinal AD-related clinical symptoms. Moreover, our interpretability strategy reveals both established and novel neural systems-level and sex-specific biomarkers, offering new insights into the neurobiological mechanisms underlying AD progression. Our findings highlight the potential of spatio-temporal graph-based learning for early, individualized prediction of AD progression, even in the context of irregularly-sampled longitudinal imaging data.

Purpose: Convolutional neural networks (CNNs) are promising in predicting treatment outcome for pediatric craniopharyngioma while the decision mechanisms are difficult to interpret. We compared the activation maps of CNN with hand crafted radiomics features of a densely connected artificial neural network (ANN) to correlate with clinical decisions. Methods: A cohort of 100 pediatric craniopharyngioma patients were included. Binary tumor progression was classified by an ANN and CNN with input of T1w, T2w, and FLAIR MRI. Hand-crafted radiomic features were calculated from the MRI using the LifeX software and key features were selected by Group lasso regularization, comparing to the activation maps of CNN. We evaluated the radiomics models by accuracy, area under receiver operational curve (AUC), and confusion matrices. Results: The average accuracy of T1w, T2w, and FLAIR MRI was 0.85, 0.92, and 0.86 (ANOVA, F = 1.96, P = 0.18) with ANN; 0.83, 0.81, and 0.70 (ANOVA, F = 10.11, P = 0.003) with CNN. The average AUC of ANN was 0.91, 0.97, and 0.90; 0.86, 0.88, and 0.75 of CNN for the 3 MRI, respectively. The activation maps were correlated with tumor shape, min and max intensity, and texture features. Conclusions: The tumor progression for pediatric patients with craniopharyngioma achieved promising accuracy with ANN and CNN model. The activation maps extracted from different levels were interpreted with hand-crafted key features of ANN.

Magnetic Resonance Imaging (MRI) is a critical medical imaging modality in clinical diagnosis and research, yet its complexity and heterogeneity pose challenges for automated analysis, particularly in scalable and generalizable machine learning applications. While foundation models have revolutionized natural language and vision tasks, their application to MRI remains limited due to data scarcity and narrow anatomical focus. In this work, we present Decipher-MR, a 3D MRI-specific vision-language foundation model trained on a large-scale dataset comprising 200,000 MRI series from over 22,000 studies spanning diverse anatomical regions, sequences, and pathologies. Decipher-MR integrates self-supervised vision learning with report-guided text supervision to build robust, generalizable representations, enabling effective adaptation across broad applications. To enable robust and diverse clinical tasks with minimal computational overhead, Decipher-MR supports a modular design that enables tuning of lightweight, task-specific decoders attached to a frozen pretrained encoder. Following this setting, we evaluate Decipher-MR across diverse benchmarks including disease classification, demographic prediction, anatomical localization, and cross-modal retrieval, demonstrating consistent performance gains over existing foundation models and task-specific approaches. Our results establish Decipher-MR as a scalable and versatile foundation for MRI-based AI, facilitating efficient development across clinical and research domains.

Low back pain affects millions worldwide, driving the need for robust diagnostic models that can jointly analyze complex medical images and accompanying text reports. We present LumbarCLIP, a novel multimodal framework that leverages contrastive language-image pretraining to align lumbar spine MRI scans with corresponding radiological descriptions. Built upon a curated dataset containing axial MRI views paired with expert-written reports, LumbarCLIP integrates vision encoders (ResNet-50, Vision Transformer, Swin Transformer) with a BERT-based text encoder to extract dense representations. These are projected into a shared embedding space via learnable projection heads, configurable as linear or non-linear, and normalized to facilitate stable contrastive training using a soft CLIP loss. Our model achieves state-of-the-art performance on downstream classification, reaching up to 95.00% accuracy and 94.75% F1-score on the test set, despite inherent class imbalance. Extensive ablation studies demonstrate that linear projection heads yield more effective cross-modal alignment than non-linear variants. LumbarCLIP offers a promising foundation for automated musculoskeletal diagnosis and clinical decision support.

Understanding what deep learning (DL) models learn is essential for the safe deployment of artificial intelligence (AI) in clinical settings. While previous work has focused on pixel-based explainability methods, less attention has been paid to the textual concepts learned by these models, which may better reflect the reasoning used by clinicians. We introduce Mammo-CLIP Dissect, the first concept-based explainability framework for systematically dissecting DL vision models trained for mammography. Leveraging a mammography-specific vision-language model (Mammo-CLIP) as a "dissector," our approach labels neurons at specified layers with human-interpretable textual concepts and quantifies their alignment to domain knowledge. Using Mammo-CLIP Dissect, we investigate three key questions: (1) how concept learning differs between DL vision models trained on general image datasets versus mammography-specific datasets; (2) how fine-tuning for downstream mammography tasks affects concept specialisation; and (3) which mammography-relevant concepts remain underrepresented. We show that models trained on mammography data capture more clinically relevant concepts and align more closely with radiologists' workflows than models not trained on mammography data. Fine-tuning for task-specific classification enhances the capture of certain concept categories (e.g., benign calcifications) but can reduce coverage of others (e.g., density-related features), indicating a trade-off between specialisation and generalisation. Our findings show that Mammo-CLIP Dissect provides insights into how convolutional neural networks (CNNs) capture mammography-specific knowledge. By comparing models across training data and fine-tuning regimes, we reveal how domain-specific training and task-specific adaptation shape concept learning. Code and concept set are available: https://github.com/Suaiba/Mammo-CLIP-Dissect.

Purpose: We developed an artificial neural network (ANN) combining radiomics with clinical and dosimetric features to predict the extent of body mass index (BMI) increase after surgery and proton therapy, with advantage of improved accuracy and integrated key feature selection. Methods and Materials: Uniform treatment protocol composing of limited surgery and proton radiotherapy was given to 84 pediatric craniopharyngioma patients (aged 1-20 years). Post-treatment obesity was classified into 3 groups (<10%, 10-20%, and >20%) based on the normalized BMI increase during a 5-year follow-up. We developed a densely connected 4-layer ANN with radiomics calculated from pre-surgery MRI (T1w, T2w, and FLAIR), combining clinical and dosimetric features as input. Accuracy, area under operative curve (AUC), and confusion matrices were compared with random forest (RF) models in a 5-fold cross-validation. The Group lasso regularization optimized a sparse connection to input neurons to identify key features from high-dimensional input. Results: Classification accuracy of the ANN reached above 0.9 for T1w, T2w, and FLAIR MRI. Confusion matrices showed high true positive rates of above 0.9 while the false positive rates were below 0.2. Approximately 10 key features selected for T1w, T2w, and FLAIR MRI, respectively. The ANN improved classification accuracy by 10% or 5% when compared to RF models without or with radiomic features. Conclusion: The ANN model improved classification accuracy on post-treatment obesity compared to conventional statistics models. The clinical features selected by Group lasso regularization confirmed our practical observation, while the additional radiomic and dosimetric features could serve as imaging markers and mitigation methods on post-treatment obesity for pediatric craniopharyngioma patients.

Accurate and interpretable survival analysis remains a core challenge in oncology. With growing multimodal data and the clinical need for transparent models to support validation and trust, this challenge increases in complexity. We propose an interpretable multimodal AI framework to automate survival analysis by integrating clinical variables and computed tomography imaging. Our MultiFIX-based framework uses deep learning to infer survival-relevant features that are further explained: imaging features are interpreted via Grad-CAM, while clinical variables are modeled as symbolic expressions through genetic programming. Risk estimation employs a transparent Cox regression, enabling stratification into groups with distinct survival outcomes. Using the open-source RADCURE dataset for head and neck cancer, MultiFIX achieves a C-index of 0.838 (prediction) and 0.826 (stratification), outperforming the clinical and academic baseline approaches and aligning with known prognostic markers. These results highlight the promise of interpretable multimodal AI for precision oncology with MultiFIX.

Breast cancer screening with mammography remains central to early detection and mortality reduction. Deep learning has shown strong potential for automating mammogram interpretation, yet limited-resolution datasets and small sample sizes continue to restrict performance. We revisit the Mini-DDSM dataset (9,684 images; 2,414 patients) and introduce a lightweight region-of-interest (ROI) augmentation strategy. During training, full images are probabilistically replaced with random ROI crops sampled from a precomputed, label-free bounding-box bank, with optional jitter to increase variability. We evaluate under strict patient-level cross-validation and report ROC-AUC, PR-AUC, and training-time efficiency metrics (throughput and GPU memory). Because ROI augmentation is training-only, inference-time cost remains unchanged. On Mini-DDSM, ROI augmentation (best: p_roi = 0.10, alpha = 0.10) yields modest average ROC-AUC gains, with performance varying across folds; PR-AUC is flat to slightly lower. These results demonstrate that simple, data-centric ROI strategies can enhance mammography classification in constrained settings without requiring additional labels or architectural modifications.